These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33706167)

  • 41. In silico investigation of the impact of synonymous variants in ABCB4 gene on mRNA stability/structure, splicing accuracy and codon usage: Potential contribution to PFIC3 disease.
    Khabou B; Siala-Sahnoun O; Gargouri L; Mkaouar-Rebai E; Keskes L; Hachicha M; Fakhfakh F
    Comput Biol Chem; 2016 Dec; 65():103-109. PubMed ID: 27788395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of functional variant in GDF1 promoter with risk of congenital heart disease and its regulation by Nkx2.5.
    Gao X; Zheng P; Yang L; Luo H; Zhang C; Qiu Y; Huang G; Sheng W; Ma X; Lu C
    Clin Sci (Lond); 2019 Jun; 133(12):1281-1295. PubMed ID: 31171573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CITED2 affects leukemic cell survival by interfering with p53 activation.
    Mattes K; Berger G; Geugien M; Vellenga E; Schepers H
    Cell Death Dis; 2017 Oct; 8(10):e3132. PubMed ID: 29072699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A New TBX5 Loss-of-Function Mutation Contributes to Congenital Heart Defect and Atrioventricular Block.
    Zhang Y; Sun YM; Xu YJ; Zhao CM; Yuan F; Guo XJ; Guo YH; Yang CX; Gu JN; Qiao Q; Wang J; Yang YQ
    Int Heart J; 2020 Jul; 61(4):761-768. PubMed ID: 32641638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CITED2 Restrains Proinflammatory Macrophage Activation and Response.
    Kim GD; Das R; Rao X; Zhong J; Deiuliis JA; Ramirez-Bergeron DL; Rajagopalan S; Mahabeleshwar GH
    Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CITED2 Cooperates with ISL1 and Promotes Cardiac Differentiation of Mouse Embryonic Stem Cells.
    Pacheco-Leyva I; Matias AC; Oliveira DV; Santos JM; Nascimento R; Guerreiro E; Michell AC; van De Vrugt AM; Machado-Oliveira G; Ferreira G; Domian I; Bragança J
    Stem Cell Reports; 2016 Dec; 7(6):1037-1049. PubMed ID: 27818139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Germline hereditary, somatic mutations and microRNAs targeting-SNPs in congenital heart defects.
    Sabina S; Pulignani S; Rizzo M; Cresci M; Vecoli C; Foffa I; Ait-Ali L; Pitto L; Andreassi MG
    J Mol Cell Cardiol; 2013 Jul; 60():84-9. PubMed ID: 23583740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The transcription factor Vezf1 represses the expression of the antiangiogenic factor Cited2 in endothelial cells.
    AlAbdi L; He M; Yang Q; Norvil AB; Gowher H
    J Biol Chem; 2018 Jul; 293(28):11109-11118. PubMed ID: 29794136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2.
    Bragança J; Swingler T; Marques FI; Jones T; Eloranta JJ; Hurst HC; Shioda T; Bhattacharya S
    J Biol Chem; 2002 Mar; 277(10):8559-65. PubMed ID: 11744733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High Glucose-Repressed CITED2 Expression Through miR-200b Triggers the Unfolded Protein Response and Endoplasmic Reticulum Stress.
    Gu H; Yu J; Dong D; Zhou Q; Wang JY; Fang S; Yang P
    Diabetes; 2016 Jan; 65(1):149-63. PubMed ID: 26450995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CITED2 is expressed in human adrenocortical cells and regulated by basic fibroblast growth factor.
    Haase M; Schott M; Bornstein SR; Malendowicz LK; Scherbaum WA; Willenberg HS
    J Endocrinol; 2007 Feb; 192(2):459-65. PubMed ID: 17283246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cited2 is required for normal hematopoiesis in the murine fetal liver.
    Chen Y; Haviernik P; Bunting KD; Yang YC
    Blood; 2007 Oct; 110(8):2889-98. PubMed ID: 17644732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utilization of Whole Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.
    LaHaye S; Corsmeier D; Basu M; Bowman JL; Fitzgerald-Butt S; Zender G; Bosse K; McBride KL; White P; Garg V
    Circ Cardiovasc Genet; 2016 Aug; 9(4):320-9. PubMed ID: 27418595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
    Liu YC; Chang PY; Chao CC
    Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel mutations of the SRF gene in Chinese sporadic conotruncal heart defect patients.
    Mengmeng X; Yuejuan X; Sun C; Yanan L; Fen L; Kun S
    BMC Med Genet; 2020 May; 21(1):95. PubMed ID: 32380971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Codon-Resolution Analysis Reveals a Direct and Context-Dependent Impact of Individual Synonymous Mutations on mRNA Level.
    Chen S; Li K; Cao W; Wang J; Zhao T; Huan Q; Yang YF; Wu S; Qian W
    Mol Biol Evol; 2017 Nov; 34(11):2944-2958. PubMed ID: 28961875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and analysis of KLF13 variants in patients with congenital heart disease.
    Li W; Li B; Li T; Zhang E; Wang Q; Chen S; Sun K
    BMC Med Genet; 2020 Apr; 21(1):78. PubMed ID: 32293321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites.
    De Guzman RN; Martinez-Yamout MA; Dyson HJ; Wright PE
    J Biol Chem; 2004 Jan; 279(4):3042-9. PubMed ID: 14594809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CITED2 limits pathogenic inflammatory gene programs in myeloid cells.
    Pong Ng H; Kim GD; Ricky Chan E; Dunwoodie SL; Mahabeleshwar GH
    FASEB J; 2020 Sep; 34(9):12100-12113. PubMed ID: 32697413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Partial rescue of defects in Cited2-deficient embryos by HIF-1alpha heterozygosity.
    Xu B; Doughman Y; Turakhia M; Jiang W; Landsettle CE; Agani FH; Semenza GL; Watanabe M; Yang YC
    Dev Biol; 2007 Jan; 301(1):130-40. PubMed ID: 17022961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.